WCM
ABBV icon

Weston Capital Management’s AbbVie ABBV Stock Holding History

Weston Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$1.09M Hold
20,595
– – 1.34% 18
2013
Q3 		$921K Sell
20,595
-450
-2% -$19.9K 1.2% 18
2013
Q2 		$870K Buy
+21,045
New +$920K 1.16% 18

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Weston Capital Management's ABBV Position: Q4 2013 in Review

Weston Capital Management held its AbbVie (ABBV) position steady in Q4 2013 at 20,595 shares worth $1.09M. The position accounts for 1.34% of the portfolio, ranked #18.

Weston Capital Management first reported a position in ABBV in Q2 2013 and has held it in 3 quarters since. 1,435 funds tracked by Wall St. Rank hold ABBV as of Q4 2013.

  • Weston Capital Management held 20,595 shares of AbbVie worth $1.09M as of Q4 2013.
  • Weston Capital Management left its AbbVie share count unchanged in Q4 2013.
  • AbbVie made up 1.34% of Weston Capital Management's portfolio in Q4 2013, its #18 holding.
  • Weston Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 3 quarters since.
  • 1,435 funds tracked by Wall St. Rank held AbbVie as of Q4 2013.

Based on Weston Capital Management's 13F filing for Q4 2013, filed 3 Jan 2014.